BRG.OL
BRG.OL
NO0010657505
BORREGAARD
Loading chart...

Company Profile

Borregaard ASA engages in the development, production, and marketing of specialized biochemicals and biomaterials in Norway, rest of Europe, Asia, the United States, and internationally. It operates in three segments: BioSolutions, BioMaterials, and Fine Chemicals. The BioSolutions segment develops, produces, and sells biopolymers and biovanillin derived from lignin for agrochemicals, batteries, industrial binders, and construction, as well as to flavor and fragrance companies, and food and beverage industry. Its BioMaterials segment develops, produces, and sells speciality cellulose used as a raw material in the production of cellulose ethers, cellulose acetate, and other specialty products, as well as cellulose fibrils for industrial applications. The Fine Chemicals segment supplies fine chemical intermediates for contrast agents and advanced bioethanol. The company was incorporated in 2012 and is headquartered in Sarpsborg, Norway.

Related stocks

ELK.OL
ELK.OL • Norway
ELKEM
33.68 NOK
1.28B USD 1Y +21.9%
ACT.DE
ACT.DE • Germany
Alzchem Group AG I
159.8 EUR
1.81B USD
ACT0.DE
ACT0.DE • Germany
Alzchem Group AG N
162.9 EUR
1.85B USD 1Y +6.4%
CRBN.AS
CRBN.AS • Netherlands
CORBION
22.28 EUR
1.44B USD 1Y +30.8%
NK.PA
NK.PA • France
IMERYS
22.46 EUR
2.13B USD 1Y +1.6%
ELM.L
ELM.L • United Kingdom
ELEMENTIS PLC ORD 5P
182.2 GBp
1.36B USD 1Y +7.3%
VCT.L
VCT.L • United Kingdom
VICTREX PLC ORD 1P
942 GBp
1.09B USD 1Y +35.7%
AZE.BR
AZE.BR • Belgium
AZELIS GROUP NV
12.64 EUR
3.45B USD 1Y +4.9%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile
5 Metrics

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
5Y Volatility
25.3% p.a.
Max Drawdown (5Y)
-45.3%
Sharpe Ratio (5Y)
-0.37
Beta Factor
0.56
Size Class
Large Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.
🔴 High valuation risk: Avg P/E of 89.3 (Elevated multiple compression risk)
Strong cyclicality: The business model is sensitive to economic downturns.
🔴 Low analyst coverage – higher uncertainty in growth estimates & projections
Historical Stress Test: Maximum peak-to-trough drawdown of -46.5% in the extended horizon.
ende